AHA 2025

Latest AHA 2025 News

First-in-human Trial of CRISPR Gene-editing ANGPTL3 Safely Lowered Cholesterol and Triglycerides

Key Points: CTX310 is a first-in-class in vivo CRISPR-Cas9 therapy designed to…

Basir Gill

Providing Healthy Food + Nutrition Counseling Improved Quality of Life in HF Patients: FOOD-HF Trial

Key Points: The FOOD‑HF Trial was a single center randomized trial that…

Basir Gill

Tirzepatide Lowers MACE vs Dulaglutide in SURPASS-CVOT Patients With Heart Failure

Key Points In SURPASS-CVOT, tirzepatide was previously shown to be non-inferior to…

Alberto Castro-Molina

PCSK9-inhibitors Do Not Reduce Early Cardiac Allograft Vasculopathy: The CAVIAR Trial

Key Points The CAVIAR trial enrolled recent heart transplant recipients to receive…

Basir Gill

DAPT-MVD: Extended DAPT reduces MACCE in patients with multi-vessel disease after DES

Key Points: The optimal duration and choice of dual antiplatelet therapy (DAPT)…

Basir Gill

NOAC Monotherapy Non-Inferior to Combination Therapy for Net Adverse Clinical events in AF Patients Post–DES: ADAPT AF-DES Trial

Key Points The ADAPT AF-DES randomized trial compared NOAC monotherapy (apixaban or…

Basir Gill

Prasugrel Might be a Better Choice than Ticagrelor For DAPT after PCI for Patients with Diabetes and MVD: The TUXEDO-2 Trial

Key Points TUXEDO-2 directly compared ticagrelor vs prasugrel based DAPT in 1,800…

Basir Gill

POLY-HF: Polypill for HFrEF Shows Promise in Reducing Medication Burden Among Underserved Patients

Key Points: Patients with heart failure with reduced ejection fraction (HFrEF) often…

Basir Gill

CorCMR: Stress Cardiac MRI Uncovers Hidden Angina and Improves Quality of Life in Patients Without Obstructive Coronary Disease

Key Points: Stress cardiac MRI (CMR) enhanced diagnostic accuracy for patients with…

Basir Gill

CELEBRATE: Early Pre-hospital Subcutaneous Zalunfiban Improves Coronary Patency and Outcomes in STEMI Without Increasing Severe Bleeding

Key Points: Early pre-hospital administration of subcutaneous zalunfiban improved coronary patency and…

Basir Gill

Family-Based Intervention Reduced Blood Pressure in Adults in Rural China: The Healthy Family Program

Key Points: A community- and family-based intervention can reduce systolic blood pressure…

Basir Gill

DASH Diet Patterned Groceries Help Reduce Blood Pressure in Black Adults: The GOFRESH Trial

Key Points: The GOFRESH trial, a parallel-group randomized study, was conducted to…

Basir Gill

BETTER-BP: Offering Cash Incentives Improves Anti-Hypertensive Medication Adherence, But Not Blood Pressure Control

Key Points: Adherence to antihypertensive medications remains a persistent challenge in clinical…

Basir Gill

FAVOR IV-QVAS: Angio-FFR–Guided CABG During Valve Surgery Improves Outcomes

Key Points: The FAVOR IV-QVAS trial tested the hypothesis physiology-guided coronary artery…

Basir Gill

ABLATION Trial – Biatrial Ablation During Mitral Valve Surgery Better than LA Ablation Alone

Key Points: Persistent atrial fibrillation (AF) is common among patients with rheumatic…

Basir Gill

Oral KCl Supplementation Lowers Sodium Load and Blood Pressure in Hypertension: SSTT Trial

Key Points The See Sodium to Treat (SSTT) Trial tested whether isolated…

Basir Gill

Daily Coffee Lowers AFib Recurrence After Cardioversion: The DECAF Trial

Key Points The Does Eliminating Coffee Avoid Fibrillation (DECAF) trial is the…

Basir Gill

Two Factor XI Antibodies For the Prevention of Post- operative VTE: Results from ROXI-VTE-I and ROXI-VTE-II Trials

Key Points: ROXI-VTE-I and ROXI-VTE-II evaluated two distinct factor XI monoclonal antibodies…

Basir Gill